WASHINGTON, D.C. (February 26, 2024) – Equitable Breakthroughs in Medicine Development (EQBMED), led by Yale School of Medicine, Morehouse School of Medicine, the Research Centers in Minority Institutions Coordinating Center (RCMI) at Morehouse School of Medicine, and Vanderbilt University Medical Center, is a partnership bringing clinical trial sites closer to the community to further equity and access for diverse populations. Today, EQBMED announced the selection of the first four Learning Phase sites, moving the needle closer to a scalable and sustainable clinical trial model in historically underserved communities. The partnerships include:

The selection of these sites is part of EQBMED’s plan to identify an initial 10 community-facing clinical trial sites in historically underrepresented communities of color across the country.

EQBMED’s multi-stakeholder model employs a holistic approach that considers the baseline capabilities of each site, allowing EQBMED to focus on creating opportunities for communities of color to participate and stay true to the program’s mission to promote clinical trial access and education.

One Response

Leave a Reply

Your email address will not be published. Required fields are marked *

The Learning Phase includes:

  • Connecting Clinical Trial Sponsors: Bringing sponsors and local EQBMED-selected sites together to work as partners.
  • Sharing Key Learnings: Sharing important lessons learned from these partnerships.
  • Building Robust Infrastructure: Creating a strong support system that continues to support the growth and aspirations of local sites.